As STAT’s Helen Branswell writes, mRNA vaccines are the fastest to make and the easiest to mass produce.

A synthetic vaccine for Helicobacter pylori designed by a team of undergraduate linkurl:students from Slovenia;http://2008.igem.org/Team:Slovenia took the grand prize ...

That’s in part because the oil is an abundant source of squalene, a critical component in some vaccines that acts as an adjuvant to drive a stronger, more durable immune response. Now, using synthetic ...

Beijing Synthetic Vaccine Biosciences Co. Ltd. has synthesized Toll-like receptor 8 (TLR8) agonists reported to be useful for the treatment of autoimmune disease, cancer, inflammatory disorders and ...

The company’s proprietary Digital Immune Optimized Synthetic Vaccine (DIOSynVax) platform uses artificial intelligence to create safer and stronger vaccines for today and smarter for tomorrow.

Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN-101 DNA plasmid vaccine. The investigational vaccine, based on the company ...

Peptide-based vaccines deliver tumor-specific antigens to dendritic cells (DCs), triggering tumor-targeted T-cell responses. A peptide-peptide conjugate technology previously developed by researchers ...

In principle, mRNA vaccines are ideal for health emergencies ... aims to overcome these challenges by generating automated synthetic DNA templates, which don’t need to be grown in living cells ...